(Q33396833)

English

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Akiko Meguro

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Katsutoshi Ozaki

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuya Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Iekuni Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shinichiro Fujiwara

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rie Hosonuma

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Miyuki Sasazaki

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yuji Kikuchi

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yuji Hirata

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chihiro Yamamoto

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mitsuyo Uesawa

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroyuki Kobayashi

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Haruko Matsu

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroshi Okabe

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eisuke Uehara

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Akinori Nishikawa

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Raine Tatara

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kaoru Hatano

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chizuru Yamamoto

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tomohiro Matsuyama

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masaki Toshima

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masuzu Ueda

22

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ken Ohmine

23

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Takahiro Suzuki

24

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masaki Mori

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tadashi Nagai

26

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuo Muroi

27

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Keiya Ozawa

28

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

24 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

43-49

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Aggressive lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Stromal gene signatures in large-B-cell lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Diffuse large B-cell lymphoma in the older

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600486

21 January 2018

Identifiers

10.3109/10428194.2011.600486

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33396833&oldid=1561083569"